Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

NTLA Intellia Therapeutics Inc

25,78

-0,39 (-1,49%)

17 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Intellia Therapeutics (NASDAQ:NTLA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Intellia Therapeutics Charts.

Intellia Therapeutics (NASDAQ:NTLA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Intellia Therapeutics Charts.

News Intellia Therapeutics Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
Donnerstag 9 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates
Donnerstag 2 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Intellia Therapeutics to Present Updated Data from Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Congress 2024
Montag 29 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy
Montag 18 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Montag 26 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Intellia Therapeutics Inc News-Artikel

ABEVQ180 Ex:17,38

ProShares Trust

MIS3 - MITH Shares v3

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen